Influenza is a disease of public health importance due to the substantial seasonal morbidity and mortality and the high pandemic potential of its aetiologic agents, influenza viruses. Diagnosis of influenza is mainly based on laboratory testing (i.e. molecular testing) of nasopharyngeal samples....

The end of 2019 saw the emergence of a novel severe acute respiratory syndrome: coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19). As of December 2023, eight vaccines (Comirnaty, Spikevax, Vaxzevria, Jcovden Valneva, Nuvaxovid, VidPrevtyn, and Bimervax) have been...

This protocol presents a common updated methodology to estimate vaccine effectiveness (VE) for COVID-19, using established health data registries in participating European Union and European Economic Area (EU/EEA) countries. This work is performed within the Vaccine Effectiveness, Burden and...

This protocol presents a common methodology to estimate vaccine effectiveness (VE) for COVID-19, using established health data registries in participating EU/EEA Member States. This work is performed within the Vaccine Effectiveness, Burden and Impact Studies (VEBIS) framework contract. A pilot...

The end of 2019 saw the emergence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19). By early August 2022, over 160 million cases and over one million deaths had been reported in the European Union/European Economic Area...

Rotavirus (RV) is the most common cause of gastroenteritis in children worldwide. It has been estimated that by the age of five years, nearly every child in the world has been infected with RV at least once. Studies suggest that RV infections lead to approximately 700 000 outpatient visits...

Since 2006, two oral live vaccines (RV1 and RV5) have been available in the European Union/European Economic Area (EU/EEA) for prevention of rotavirus-induced gastroenteritis (RVGE). The main objective of rotavirus vaccination in organised national immunisation programmes is to provide...

In Europe, influenza occurs in regular annual epidemics in the winter season. Annual influenza epidemics are associated with high morbidity and mortality. Severe illness and complications are more common in certain risk groups, which include those with chronic medical conditions (e.g....

In Europe, influenza occurs in regular annual epidemics in the winter season. Annual influenza epidemics are associated with high morbidity and mortality. Severe illness and complications are more common in certain risk groups. These include those with chronic medical conditions (e.g....

Featuring influenza vaccine effectiveness in adults 65 years and older, Denmark, 2015/16 - a rapid epidemiological and virological assessment; concordance of interim and final estimates of influenza vaccine effectiveness: a systematic review; importance of timely monitoring of seasonal influenza...